Back
Speaker illustration

Doctor Vidya Perera

Bayer, Princeton (United States of America)

Member of:

European Society of Cardiology

Presentations

First-in-human study to assess the safety, pharmacokinetics and pharmacodynamics of BMS-986177/JNJ-70033093, a direct, reversible, small molecule Factor XIa inhibitor in healthy volunteers

Event: ESC Congress 2020

Topic: Anticoagulants

Session: Antithrombotic Therapy Update

Access
Like
Thumbnail

Single-dose pharmacokinetics of BMS-986177/JNJ-70033093 in participants with mild or moderate hepatic impairment compared to healthy participants

Event: ESC Congress 2020

Topic: Anticoagulants

Session: Pharmacology and Pharmacotherapy ePosters

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources